Duramed Investigational Site

San Antonio, Texas 78258

0 studies enrolling now · 12 studies all time

What they study most

Breakthrough Bleeding, Contraception, Endometriosis, Hot Flashes, Menopause, Migraine, Nocturnal Vasomotor Symptoms, Overactive Bladder, Prostate Cancer, Urinary Incontinence

Studies at this site

• A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches — Completed
• Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive — Completed
• A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients — Completed
• A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder — Completed
• A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy — Completed
• Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain — Completed
• A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy — Completed
• Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive — Completed
• A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale — Completed
• Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women — Completed
• Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder — Completed
• A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes — Completed